257 related articles for article (PubMed ID: 22808957)
1. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Nowroozalizadeh S; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
N Engl J Med; 2012 Jul; 367(3):224-32. PubMed ID: 22808957
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
[TBL] [Abstract][Full Text] [Related]
3. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
6. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
[TBL] [Abstract][Full Text] [Related]
9. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
[TBL] [Abstract][Full Text] [Related]
11. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
[TBL] [Abstract][Full Text] [Related]
13. [Influence of the viral subtype in the progression of HIV patients].
Fonseca Gómez C; Pérez Avila J; Pérez Santos L
Rev Cubana Med Trop; 2007; 59(3):247-53. PubMed ID: 23427464
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.
Rachinger A; Kootstra NA; Gijsbers EF; van den Kerkhof TL; Schuitemaker H; van 't Wout AB
AIDS; 2012 Jul; 26(12):1517-22. PubMed ID: 22555160
[TBL] [Abstract][Full Text] [Related]
15. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
[TBL] [Abstract][Full Text] [Related]
16. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
Pantaleo G; Menzo S; Vaccarezza M; Graziosi C; Cohen OJ; Demarest JF; Montefiori D; Orenstein JM; Fox C; Schrager LK
N Engl J Med; 1995 Jan; 332(4):209-16. PubMed ID: 7808486
[TBL] [Abstract][Full Text] [Related]
17. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
19. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein is a marker for human immunodeficiency virus disease progression.
Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
